This taboo-busting series investigates the rise in popularity of controversial GLP-1 weight loss medications such as Ozempic, Wegovy and Mounjaro. Kathryn Thomas investigates how GLP-1 medications are reshaping our understanding of obesity and challenging decades of thinking around weight, willpower and personal responsibility.

Through intimate access to people taking the medication, the series reveals both the promise and the price of rapid weight loss: reduced risk of diabetes and heart disease alongside difficult side effects, fears of long-term dependency, and the psychological impact of dramatic body change.

At the same time, Kathryn examines how celebrity culture and social media have propelled these drugs into the beauty and wellness marketplace, raising concerns that they may reinforce harmful body ideals and revive a culture where thinness is equated with moral worth.

We learn why we still need to address the root cause of obesity alongside these "wonder drugs" and ask the question on everyone’s lips: are these drugs just another quick fix in our toxic diet culture?